TEMOSIDE 20MG CAPSULES
| Product Name | Temoside Capsule |
|---|---|
| Strength | 20 mg |
| Active Ingredient | Temozolomide |
| Drug Class | Alkylating Agent |
| Form | Capsule |
| Route of Administration | Oral |
| Packaging | Bottle / Blister strip (as per manufacturer) |
| Storage Condition | Store below 30°C, protect from moisture |
| Prescription Required | Yes |
| Usage | Glioblastoma multiforme, anaplastic astrocytoma |
TEMOSIDE 20MG CAPSULES
Temoside 20mg Capsules contain temozolomide, an oral alkylating chemotherapy medicine widely used in the treatment of glioblastoma multiforme and anaplastic astrocytoma. It is an effective anticancer drug commonly prescribed in neuro-oncology for managing aggressive brain tumors. Its oral capsule form offers convenient administration as part of a structured cancer treatment plan.
Temozolomide works by damaging the DNA of cancer cells, which stops their ability to grow, divide, and spread. By targeting rapidly multiplying tumor cells, Temoside 20 mg Capsule helps slow disease progression and improve treatment outcomes. It is often used alone or in combination with radiotherapy, depending on the patient’s condition and treatment protocol.
Temoside 20 mg Capsule is a prescription-only chemotherapy medicine and should be taken strictly under the supervision of a qualified oncologist. Proper dosage and monitoring are essential to ensure safety and effectiveness. This product is suitable for hospitals, oncology clinics, and authorized pharmaceutical supplies, making it a reliable option in modern brain cancer therapy.
Product Features
- Oral alkylating chemotherapy capsule
- Contains Temozolomide 20 mg
- Used in brain tumors and gliomas
- Crosses the blood–brain barrier effectively
- Suitable for outpatient cancer therapy
- Administered in cycles as prescribed
- Manufactured under GMP-compliant standards
- Prescription-required anticancer medicine
How It Helps
- Damages cancer cell DNA to stop tumor growth
- Slows the multiplication of brain tumor cells
- Effectively reaches tumors by crossing the blood–brain barrier
- Supports controlled and targeted brain cancer treatment

Reviews
There are no reviews yet.